PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Por um escritor misterioso
Descrição
Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?, Intensive Care Medicine Experimental
Differential Between Self-Limited Statin Myopathy and Statin-Associated
Novel potassium binders: a clinical update
PDF) Statin-induced myopathy: A review and update
Genetic and immunologic susceptibility to statin-related myopathy.
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations: Molecular Therapy
2018 Guidelines for the management of dyslipidemia
Phenotype Standardization for Statin‐Induced Myotoxicity - Alfirevic - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Diagnostics, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
